-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Pharma launches underwritten public offering of shares and warrants

PUBT·05/21/2026 20:01:24
Listen to the news
NervGen Pharma launches underwritten public offering of shares and warrants
  • NervGen launched an underwritten public offering of common shares with accompanying warrants to buy common shares.
  • Some investors may receive pre-funded warrants in lieu of common shares, also paired with common share warrants.
  • Proceeds earmarked to advance NVG-291 through clinical studies, with the remainder for general corporate purposes.
  • Leerink Partners, TD Cowen named as joint bookrunners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NervGen Pharma Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605211601PRIMZONEFULLFEED9724976) on May 21, 2026, and is solely responsible for the information contained therein.